Your browser doesn't support javascript.
loading
Multiparameters associated to successful weaning from VA ECMO in adult patients with cardiogenic shock or cardiac arrest: Systematic review and meta-analysis.
Burgos, Lucrecia María; Seoane, Leonardo; Diez, Mirta; Baro Vila, Rocío Consuelo; Furmento, Juan Francisco; Vrancic, Mariano; Aissaoui, Nadia.
Afiliação
  • Burgos LM; Heart Failure, Pulmonary Hypertension and Transplant Department, Instituto Cardiovascular de Buenos Aires (ICBA), Buenos Aires, Argentina.
  • Seoane L; Critical care Cardiology Department, Instituto Cardiovascular de Buenos Aires (ICBA), Buenos, Aires, Argentina.
  • Diez M; Heart Failure, Pulmonary Hypertension and Transplant Department, Instituto Cardiovascular de Buenos Aires (ICBA), Buenos Aires, Argentina.
  • Baro Vila RC; Heart Failure, Pulmonary Hypertension and Transplant Department, Instituto Cardiovascular de Buenos Aires (ICBA), Buenos Aires, Argentina.
  • Furmento JF; Critical care Cardiology Department, Instituto Cardiovascular de Buenos Aires (ICBA), Buenos, Aires, Argentina.
  • Vrancic M; Cardiac Surgery Department, Instituto Cardiovascular de Buenos Aires (ICBA), Buenos, Aires, Argentina.
  • Aissaoui N; Penn State Heart and Vascular Institute (HVI), Critical Care Unit, Penn State Health Milton S. Hershey Medical Center (HMC) and Penn State University. Hershey, USA and INSERM 970, Paris, France.
Ann Card Anaesth ; 26(1): 4-11, 2023.
Article em En | MEDLINE | ID: mdl-36722581
ABSTRACT
Venoarterial extracorporeal membrane oxygenation (VA ECMO) is a form of temporary mechanical circulatory support and simultaneous extracorporeal gas exchange for acute cardiorespiratory failure, including refractory cardiogenic shock (CS) and cardiac arrest (CA). Few studies have assessed predictors of successful weaning (SW) from VA ECMO. This systematic review and meta-analysis aimed to identify a multiparameter strategy associated with SW from VA ECMO. PubMed and the Cochrane Library and the International Clinical Trials Registry Platform were searched. Studies reporting adult patients with CS or CA treated with VA ECMO published from the year 2000 onwards were included. Primary outcomes were hemodynamic, laboratory, and echocardiography parameters associated with a VA ECMO SW. A total of 11 studies (n=653) were included in this review. Pooled VA ECMO SW was 45% (95%CI 39-50%, I2 7%) and in-hospital mortality rate was 46.6% (95%CI 33-60%; I2 36%). In the SW group, pulse pressure [MD 12.7 (95%CI 7.3-18) I2 = 0%] and mean blood pressure [MD 20.15 (95%CI 13.8-26.4 I2 = 0) were higher. They also had lower values of creatinine [MD -0.59 (95%CI -0.9 to -0.2) I2 = 7%], lactate [MD -3.1 (95%CI -5.4 to -0.7) I2 = 89%], and creatine kinase [-2779.5 (95%CI -5387 to -171) I2 = 38%]. And higher left and right ventricular ejection fraction, MD 17.9% (95%CI -0.2-36.2) I2 = 91%, and MD 15.9% (95%CI 11.9-20) I2 = 0%, respectively. Different hemodynamic, laboratory, and echocardiographic parameters were associated with successful device removal. This systematic review demonstrated the relationship of multiparametric assessment on VA ECMO SW.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxigenação por Membrana Extracorpórea / Parada Cardíaca Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxigenação por Membrana Extracorpórea / Parada Cardíaca Idioma: En Ano de publicação: 2023 Tipo de documento: Article